American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

The Department of Pharmaceuticals, Government of India, organised an Industry dialogue on the Promotion of Research and ...

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian Pharmaceutical Alliance, which refuted the study's claims. The study ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...